New immunotherapy shows promising results in subgroup of people with type 1 diabetes

By | May 24, 2021
A clinical study led by Linköping University and financed by pharmaceuticals company Diamyd Medical has investigated whether immunotherapy against type 1 diabetes can preserve the body’s own production of insulin.